Search

everythinglearnresearchcommunity

for

Search:↓

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Upadacitinib may effectively treat resistant lichen planopilaris.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Calcipotriol scalp solution works better than coal tar shampoo for treating scalp psoriasis and is safe for long-term use.

Apremilast showed mixed results for treating severe alopecia areata.

High-potency steroids or tacrolimus are effective treatments for Erosive Pustular Dermatosis of the Scalp.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

Different treatments for skin conditions were found to be effective and generally safe, with biologics recommended as the first choice for generalized pustular psoriasis.

JAK inhibitors show promise in treating difficult skin diseases.

The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.

New cytokine-targeted therapies show promise for treating alopecia areata.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Targeting protein S-palmitoylation could lead to new skin disease treatments.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Vitamin D supplements should be used cautiously in sarcoidosis patients, with regular monitoring to avoid high calcium levels.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.